The external validation of the asthma prediction tool in the French ELFE cohort

Sadia Khan1, El Hassane Ouaalaya1, Jonviea D Chamberlain2,3

  • 1Bordeaux Population Health Research Center, EPICENE Team, INSERM, UMR 1219, Bordeaux University, Bordeaux, France.

Pediatric Pulmonology
|August 4, 2022
PubMed

Insights

A noninvasive asthma prediction tool (APT) effectively identified children at high risk for asthma in a French cohort. This tool shows promise for primary care use, aiding early asthma detection in children.

Area of Science:

  • Pediatric Pulmonology
  • Epidemiology
  • Biostatistics

Background:

  • Current asthma prediction scores for children often require invasive procedures, limiting their use in primary care.
  • The Leicestershire Respiratory Cohort (LRC) developed a noninvasive Asthma Prediction Tool (APT) with promising initial results.
  • External validation of the APT in a large French general population cohort (ELFE) was conducted.

Purpose of the Study:

  • To externally validate the noninvasive Asthma Prediction Tool (APT) in the French general population.
  • To assess the performance and generalizability of the APT for identifying children at risk of developing asthma.
  • To evaluate the APT's utility in a primary care setting.

Main Methods:

  • The APT was applied to children in the Étude Longitudinale Française depuis l'Enfance (ELFE) cohort at Age 1.
  • Asthma was defined at Age 5 by parental report of "asthma ever" or "wheezing in the past 12 months".
  • Logistic regression, receiver operating characteristic (ROC) curves (AUC), Brier scores, and Hosmer-Lemeshow tests were used for performance and calibration assessment.

Main Results:

  • The APT categorized 84.9% of 10,689 children as low-risk, 13.1% as medium-risk, and 2% as high-risk for asthma at Age 5.
  • Children in the high-risk category were 13 times more likely to develop asthma (OR=13.8, 95% CI=10.2-18.8).
  • The APT demonstrated comparable performance in the ELFE cohort (AUC=0.68, Brier score=0.14) to the LRC cohort (AUC=0.74, Brier score=0.16), indicating robust discriminative ability and calibration.

Conclusions:

  • The external validation confirms the APT's effectiveness in identifying children at risk for asthma in a general French population.
  • The noninvasive nature and robust performance of the APT support its potential application by general practitioners for early asthma detection.
  • The study provides further evidence for the APT's comprehensive measure of effectiveness, encouraging its use in primary care settings.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
551
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
432